|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakuragi N: Refining insight into cervical
cancer progression. Lancet Oncol. 15:371–372. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brooks SE, Chen TT, Ghosh A, Mullins CD,
Gardner JF and Baquet CR: Cervical cancer outcomes analysis: Impact
of age, race, and comorbid illness on hospitalizations for invasive
carcinoma of the cervix. Gynecol Oncol. 79:107–115. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Waggoner SE: Cervical cancer. Lancet.
361:2217–2225. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barbera L and Thomas G: Management of
early and locally advanced cervical cancer. Semin Oncol.
36:155–169. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: microRNAs in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu X, Schwarz JK, Lewis JS Jr, Huettner
PC, Rader JS, Deasy JO, Grigsby PW and Wang X: A microRNA
expression signature for cervical cancer prognosis. Cancer Res.
70:1441–1448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Peng R, Men J, Ma R, Wang Q, Wang Y, Sun Y
and Ren J: miR-214 down-regulates ARL2 and suppresses growth and
invasion of cervical cancer cells. Biochem Biophys Res Commun.
484:623–630. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dang H, Zheng P, Liu Y and Wu X and Wu X:
MicroRNA-543 acts as a prognostic marker and promotes the cell
proliferation in cervical cancer by BRCA1-interacting protein 1.
Tumour Biol. 39:10104283176911872017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun M, Nie F, Wang Y, Zhang Z, Hou J, He
D, Xie M, Xu L, De W, Wang Z, et al: lncRNA HOXA11-AS promotes
proliferation and invasion of gastric cancer by scaffolding the
chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Res.
76:6299–6310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang C, Chi YL, Wang PY, Wang YQ, Zhang
YX, Deng J, Lv CJ and Xie SY: miR-511 and miR-1297 inhibit human
lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.
PLoS One. 7:e460902012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu C, Wang C, Wang J and Huang H:
miR-1297 promotes cell proliferation by inhibiting RB1 in liver
cancer. Oncol Lett. 12:5177–5182. 2016.PubMed/NCBI
|
|
15
|
Liu F, He Y, Shu R and Wang S:
MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation
and apoptosis by targeting EZH2. Int J Clin Exp Pathol.
8:4972–4980. 2015.PubMed/NCBI
|
|
16
|
Li X, Wang HL, Peng X, Zhou HF and Wang X:
miR-1297 mediates PTEN expression and contributes to cell
progression in LSCC. Biochem Biophys Res Commun. 427:254–260. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang NQ, Luo XJ, Zhang J, Wang GM and Guo
JM: Crosstalk between Meg3 and miR-1297 regulates growth of
testicular germ cell tumor through PTEN/PI3K/AKT pathway. Am J
Transl Res. 8:1091–1099. 2016.PubMed/NCBI
|
|
18
|
Liang X, Li H, Fu D, Chong T, Wang Z and
Li Z: MicroRNA-1297 inhibits prostate cancer cell proliferation and
invasion by targeting the AEG-1/Wnt signaling pathway. Biochem
Biophys Res Commun. 480:208–214. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen P, Wang BL, Pan BS and Guo W:
MiR-1297 regulates the growth, migration and invasion of colorectal
cancer cells by targeting cyclo-oxygenase-2. Asian Pac J Cancer
Prev. 15:9185–9190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qureshi R, Arora H and Rizvi MA: EMT in
cervical cancer: Its role in tumour progression and response to
therapy. Cancer Lett. 356:321–331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Z, Dou C, Yao B, Xu M, Ding L, Wang Y,
Jia Y, Li Q, Zhang H, Tu K, et al: Methylation-mediated repression
of microRNA-129-2 suppresses cell aggressiveness by inhibiting high
mobility group box 1 in human hepatocellular carcinoma. Oncotarget.
7:36909–36923. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Z, Dou C, Yao B, Xu M, Ding L, Wang Y,
Jia Y, Li Q, Zhang H, Tu K, et al: Ftx non coding RNA-derived
miR-545 promotes cell proliferation by targeting RIG-I in
hepatocellular carcinoma. Oncotarget. 7:25350–25365. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Xu X, Mo S, Tian Y, Wu J, Zhang J
and Zhao J: Involvement of microRNA-1297, a new regulator of HMGA1,
in the regulation of glioma cell growth in vivo and in vitro. Am J
Transl Res. 8:2149–2158. 2016.PubMed/NCBI
|
|
25
|
Liu Y, Liang H and Jiang X: miR-1297
promotes apoptosis and inhibits the proliferation and invasion of
hepatocellular carcinoma cells by targeting HMGA2. Int J Mol Med.
36:1345–1352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang NQ, Zhang J, Tang QY, Guo JM and Wang
GM: miRNA-1297 induces cell proliferation by targeting phosphatase
and tensin homolog in testicular germ cell tumor cells. Asian Pac J
Cancer Prev. 15:6243–6246. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deftereos G, Corrie SR, Feng Q, Morihara
J, Stern J, Hawes SE and Kiviat NB: Expression of mir-21 and
mir-143 in cervical specimens ranging from histologically normal
through to invasive cervical cancer. PLoS One. 6:e284232011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang K, Li LA, Meng Y, You Y, Fu X and
Song L: High expression of astrocyte elevated gene-1 (AEG-1) is
associated with progression of cervical intraepithelial neoplasia
and unfavorable prognosis in cervical cancer. World J Surg Oncol.
11:2972013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li J, Yang L, Song L, Xiong H, Wang L, Yan
X, Yuan J, Wu J and Li M: Astrocyte elevated gene-1 is a
proliferation promoter in breast cancer via suppressing
transcriptional factor FOXO1. Oncogene. 28:3188–3196. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song E, Yu W and Xiong X, Kuang X, Ai Y
and Xiong X: Astrocyte elevated gene-1 promotes progression of
cervical squamous cell carcinoma by inducing epithelial-mesenchymal
transition via Wnt signaling. Int J Gynecol Cancer. 25:345–355.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He W, He S, Wang Z, Shen H, Fang W, Zhang
Y, Qian W, Lin M, Yuan J, Wang J, et al: Astrocyte elevated gene-1
(AEG-1) induces epithelial-mesenchymal transition in lung cancer
through activating Wnt/β-catenin signaling. BMC Cancer. 15:1072015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu JQ, Zhou Q, Zhu H, Zheng FY and Chen
ZW: Overexpression of astrocyte elevated gene-1 (AEG-1) in cervical
cancer and its correlation with angiogenesis. Asian Pac J Cancer
Prev. 16:2277–2281. 2015. View Article : Google Scholar : PubMed/NCBI
|
